AngioSafe
Medical Equipment Manufacturing • 
5215 Hellyer Ave, 240, United States • 21-50 Employees
Company overview
| Headquarters | 5215 Hellyer Ave, 240, San Jose, California 95138, US |
| Phone number | +16694008383 |
| Website | |
| SIC | 737 |
| Keywords | Quality, Medical Affairs, Commercial, Regulatory, Marketing, Design Engineering, Manufacturing, Test Engineering, Safety, Quality Engineering, Clinical Sciences, Catheters, Efficacy, Critical Limb Ischemia, Nonclinical, Coronary Artery Disease, Peripheral Artery Disease, Complex Algorithms |
| Founded | 2014 |
| Employees | 21-50 |
| Socials |
Key Contacts at AngioSafe
Sarvajna Dwivedi
Ceo, Co-Founder And Board Member
Taras Bouzakine
Director, Global Regulatory Affairs
Khushbu Shah
Associate Director Of Quality
Joyce Newton
Director Sales Operations
Bradley Sinclair
Head Of Sales
Sharlynn Willingham
Director Of Clinical Affairs
Steve Brunell
Director Of R&D Consultant
AngioSafe Email Formats
AngioSafe uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@angiosafe.com), used 51.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@angiosafe.com | 51.9% |
{first initial}{last name} | jdoe@angiosafe.com | 18.5% |
{first initial} | j@angiosafe.com | 18.5% |
{first initial}.{last name} | j.doe@angiosafe.com | 7.4% |
About AngioSafe
AngioSafe® is redefining revascularization through the development of technologies that safely, efficiently, and predictably empower interventionalists to tackle complex lesions. Its proprietary Atheroplasty™ core technology platform does not require any capital equipment and simultaneously combines mechanisms and features to revascularize severely occluded arteries, simplifying one of the most complex procedures in cardiovascular interventions. With its flagship Santreva™-ATK endovascular revascularization catheter, AngioSafe is advancing a new era of vascular innovation to improve procedure outcomes and confidence for physicians addressing complex femoropopliteal interventions. Santreva-ATK is FDA cleared and CE marked and is now commercially available.
AngioSafe revenue & valuation
| Annual revenue | $2,481,095 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $8,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
AngioSafe has 22 employees across 7 departments.
Departments
Number of employees
Funding Data
AngioSafe has never raised funding before.
AngioSafe Tech Stack
Discover the technologies and tools that power AngioSafe's digital infrastructure, from frameworks to analytics platforms.
Web servers
CDN
Static site generator
JavaScript libraries
Hosting
Font scripts
Miscellaneous
UI frameworks
Netherlands
Germany
CanadaFrequently asked questions
4.8
40,000 users
